Dr. Nicholas Theodore will discuss NOCISCAN's innovative use of MR Spectroscopy and AI for chronic low back pain at the Spine Summit. Aclarion, Inc. announced its participation in the 2025 Spine ...

Please provide your email address to receive an email when new articles are posted on . Chronic low back pain is one of the most frequent and challenging conditions encountered in primary care.

Allogeneic bone marrow–derived mesenchymal stromal cells (BM-MSCs) are safe but do not show efficacy in treating intervertebral disc degeneration (IDD) in patients with chronic low back pain. The ...

Researchers found that a 12-week therapeutic virtual yoga program for chronic low back pain can be a feasible, safe and effective treatment option. Cleveland Clinic researchers found that a 12-week ...

Older adults with chronic low back pain (CLBP) had less pain and improved physical function using acupuncture compared to standard treatments, a National Institutes of Health (NIH)-funded clinical ...

Among veterans with low back pain, a sequenced care pathway and a pain navigator pathway demonstrate similar physical function outcomes.

Aclarion, Inc. is set to showcase its advanced platform, NOCISCAN, at the Selby Spine Conference, presented by Dr. Sigurd Berven. NOCISCAN combines MR Spectroscopy and augmented intelligence to ...

Dr. Howard Schubiner’s work in "Unlearn Your Pain" explores how chronic pain could be reversible with the right treatment.

Low back pain persists as the leading cause for work loss, disability and reduction of quality of life across the world. In 2020, over half a billion prevalent cases of low back pain were recorded.

Now, there’s another reason to go for that long walk on the beach. A long time spent walking each day may reduce the risk of back pain, a new study suggests. The key word here is “long.” People who ...

Forbes contributors publish independent expert analyses and insights. Sarah Sinclair is an award-winning journalist covering cannabis. Experts believe VER-01, and other similar drugs, could be a ...